Without ongoing B12 replacement, deficiency and symptoms will typically recur within months to years of discontinuation
It has been found to be key in preventing and combating a number of serious health concerns, including various types of cancer
This was made clear during the COVID-19 pandemic, with pharmacists overwhelmed not only by demand for medicines but by patients seeking guidance
Our research library covers reconstitution and concentration calculations for in-vitro work.
Prolaject TM B12 is a short-acting injectable supplement, it provides protection in a single treatment, for the treatment and control of cobalt deficiency in sheep and cattle: Maintain growth, Reduce ill thrift and support energy and immunity
Experimental models frequently investigate its potential role in angiogenesis (the formation of new blood vessels) and the upregulation of growth factor receptors